Hypo Pharyngeal Cancer Treatment
Sight:- Hypo Pharynx (The Area Where The Larynx And Esophagus Meet)
Sex Prediction:- Male And Female In Ratio 3:1
Found in patients who are mostly above 40 years of age very rare in people below 30. Most cases found in men between the ages 55-70.
Heavy alcohol use
Diagnosis Of Hypo Pharyngeal Cancer:-
There are several ways to diagnose Hypo pharyngeal Cancer
The doctor checks for swollen lymph nodes and may look down the patient’s throat with a long handled mirror called laryngoscope.
Endoscopy Esophagoscopy or Bronchoscopy:-
Inserted into the nose or mouth of the patient, this a thin, lighted tube that allows the doctor to see farther down the throat, into the esophagus or into the trachea.
This is a small tissue sample that can be acquired during an endoscopy, esophagoscopy, or bronchoscopy. The tissue is analyzed for the presences of cancer cells.
Symptoms Of Hypo Pharyngeal Cancer:-
1. Swollen Lymph Nodes in the neck (first sign of a problem in half of all patients)
2. Sore throat in one location that persists after treatment
3. Pain that radiates from the throat to the ears
4. Difficult or painful swallowing (often leads to malnutrition and weight loss because of a refusal to eat)
5. Voice changes (late stage cancer)
Treatment Of Hypo Pharyngeal Cancer:-
Except For Very Early Stage Cancers Of This Region, Treatment Has Primarily Been Surgery.
Except for very early stage cancers of this region, treatment has primarily been surgery.
The advanced-stage hypo pharyngeal cancer requires single-modality therapy along with either surgery or radiation therapy. Patients with stage III or stage IV disease are usually suggested combined-modality treatment.
When used in combination with surgery, radiation therapy is usually administered postoperative.
Combined chemotherapy and radiation therapy is known for providing effective tumor control with organ preservation as opposed to radiation therapy alone Neoadjuvant chemotherapy and radiation therapy is recommended for patients with stage III and advanced resectable stage IV cancer.